肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1325-1330.

• 肝癌 • 上一篇    下一篇

血、尿代谢标志物和肠道菌群特征对肝细胞癌的影响及临床意义

罗继杭, 刘璞玉, 罗亚文   

  1. 563000 遵义 遵义医科大学附属医院感染科(罗继杭,罗亚文);
    563000 遵义 遵义医科大学第二附属医院病理科(刘璞玉)
  • 收稿日期:2026-03-10 出版日期:2026-09-30 发布日期:2026-11-16
  • 基金资助:
    贵州省科技计划项目(黔科合基础MS〔2026〕975);遵义市科技计划项目[遵市科合HZ字(2024)440号]

Impact and clinical significance of blood and urine biomarkers and gut microbiota on hepatocellular carcinoma

Luo Jihang1, Liu Puyu2, Luo Yawen1   

  1. 1. Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, Zunyi 563000,China;
    2. Department of Pathology, the Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China
  • Received:2026-03-10 Online:2026-09-30 Published:2026-11-16

摘要: 目的 探究血、尿生物标志物及肠道菌群特征与肝细胞癌(HCC)风险的深层因果关联。方法 采用孟德尔随机化(MR)方法开展分析,构建包含逆方差加权(IVW)、MR-Egger回归、加权中位数法、贝叶斯加权MR的多维分析模型,通过双向及中介MR分析,系统评估多源生物标志物与肠道菌群对HCC易感性的因果效应。结果 C-反应蛋白(CRP)、γ-谷氨酰转肽酶(GGT)水平升高以及Firmicutes CAG-345、Klebsiella菌群丰度上升与HCC风险呈显著正相关(CRP:OR=1.56,P=0.02;GGT:OR=1.74,P<0.01;Firmicutes CAG-345:OR=1.52,P=0.01;CAG-345 sp000433315:OR=1.49,P=0.01; Klebsiella:OR=2.01,P<0.01);尿钾水平升高(尿钾:OR=0.03,P=0.02)以及Blautia sp000436935、Faecalicatena sp002161355、Leptospirales的富集,对HCC具有显著保护效应(Blautia sp000436935:OR=0.61,P=0.01;Faecalicatena sp002161355:OR=0.21,P<0.01;Leptospirales:OR=0.09,P=0.04);进一步的中介效应分析表明Blautia属丰度在尿钾降低HCC风险的机制中发挥了约占总效应14.08%(间接效应值-0.51)的中介作用。结论 特定代谢标志物和肠道微生态在HCC发病中具有因果作用。

关键词: 肝细胞癌, 孟德尔随机化分析, 生物标志物, 肠道微生物群

Abstract: Objective This study aimed to explore the underlying causal associations of blood and urinary biomarkers as well as gut microbiota characteristics with the risk of hepatocellular carcinoma (HCC). Methods Mendelian randomization (MR) was adopted for statistical analysis. A multi-dimensional analytical model was established incorporating inverse-variance-weighted (IVW), MR-Egger regression, weighted-median method, and Bayesian weighted Mendelian randomization (BWMR). Bidirectional and mediation MR analyses were further performed to systematically evaluate the causal effects of multi-source biomarkers and gut microbiota on HCC susceptibility. Results Elevated levels of C-reactive protein (CRP) and gamma-glutamyltransferase (GGT), as well as increased abundances of Firmicutes CAG-345 and Klebsiella, were significantly positively correlated with HCC risk (CRP: OR=1.56,P=0.02; GGT; OR=1.74,P<0.01; Firmicutes CAG-345: OR=1.52,P=0.01; CAG-345 sp000433315: OR=1.49, P=0.01; Klebsiella: OR=2.01, P<0.01). Increased urinary potassium level exerted a significant protective effect against HCC (urinary potassium: OR=0.03, P=0.02). Similarly, the enrichment of Blautia sp000436935, Faecalicatena sp002161355, and Leptospirales also conferred prominent protective effects against HCC (Blautia sp000436935: OR=0.61, P=0.01; Faecalicatena sp002161355: OR=0.21, P<0.01; Leptospirales: OR=0.09, P=0.04). Further mediation analysis revealed that the abundance of the genus Blautia played a mediating role, accounting for 14.08% of the total effect (indirect effect value=-0.51) in the mechanism by which urinary potassium reduced HCC risk. Conclusion This study clarified the causal roles of specific metabolic biomarkers and gut microecology in the pathogenesis of HCC.

Key words: Hepatocellular carcinoma, Mendelian randomization, Biomarkers, Gut microbiome